Use of subcutaneous treprostinil in pediatric pulmonary arterial hypertension—Bridge‐to‐transplant or long‐term treatment?

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-3046|22|2|petr.13106-petr.13106

ISSN： 1397-3142

Source： PEDIATRIC TRANSPLANTATION, Vol.22, Iss.2, 2018-03, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

bloodstream infection in a pediatric patient with pulmonary arterial hypertension receiving intravenous treprostinil therapy

By Wen A.   Weiss I.   Kelly R.  

Infection, Vol. 41, Iss. 3, 2013-06 ,pp. : 719-722

Springer Publishing Company

Access to resources Recommend Favorite

Safety, Tolerability and Clinical Effects of a Rapid Dose Titration of Subcutaneous Treprostinil Therapy in Pulmonary Arterial Hypertension: A Prospective Multi-Centre Trial

By  

Respiration, Vol. 92, Iss. 6, 2016-10 ,pp. : 362-370

Karger

Access to resources Recommend Favorite

Cost-minimization analysis of treprostinil vs. epoprostenol as an alternate to oral therapy non-responders for the treatment of pulmonary arterial hypertension

By Narine L.   Hague L. K.   Walker J. H.   Vicente C.   Schilz R.   Desjardins O.   Einarson T. R.   Iskedjian M.  

Current Medical Research and Opinion, Vol. 21, Iss. 12, 2005-12 ,pp. : 2007-2016

Informa Healthcare

Access to resources Recommend Favorite

Long-term trial of bosentan monotherapy for pulmonary arterial hypertension in Japanese patients

By Sasayama Shigetake   Satoh Toru   Izumi Tohru   Yoshida Shunji   Kyotani Shingo   Tahara Nobuhiro  

Current Medical Research and Opinion, Vol. 23, Iss. 2, 2007-02 ,pp. : 395-400

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Safety of Long-Term Imatinib Therapy for Pulmonary Arterial Hypertension

By  

Respiration, Vol. 89, Iss. 6, 2015-06 ,pp. : 515-524

Karger

Access to resources Recommend Favorite